Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Aparicio

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Genome Biology|October 16, 2014
Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscopeSamuel Aparicio, Elaine Mardis
The New England Journal of Medicine|March 1, 2013
The implications of clonal genome evolution for cancer medicineSamuel Aparicio, Carlos Caldas
Cell|September 22, 2009
p53: a new kingpin in the stem cell arenaSamuel Aparicio, Connie J Eaves
Nature Reviews. Cancer|April 25, 2015
Examining the utility of patient-derived xenograft mouse modelsSamuel Aparicio, Manuel Hidalgo, Andrew L Kung
Cold Spring Harbor Perspectives in Medicine|May 1, 2024
Breast CancerJane E Visvader, Jeffrey M Rosen, Samuel Aparicio
Current Opinion in Genetics & Development|March 6, 2012
Opening Pandora's Box--the new biology of driver mutations and clonal evolution in cancer as revealed by next generation sequencingQianli C Ma, Catherine A Ennis, Samuel Aparicio
Clinical Chemistry|December 4, 2013
The omics of triple-negative breast cancersHong Xu, Peter Eirew, Sarah C Mullaly, et al.
The EMBO Journal|February 12, 2013
A new genome-driven integrated classification of breast cancer and its implicationsSarah-Jane Dawson, Oscar M Rueda, Samuel Aparicio, et al.
Virchows Archiv : an International Journal of Pathology|April 26, 2008
Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?Gulisa Turashvili, Malcolm Hayes, Blake Gilks, et al.
Scientific Reports|May 8, 2021
Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461Tehmina Masud, Charles Soong, Hong Xu, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Genome Biology|October 16, 2014
Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscopeSamuel Aparicio, Elaine Mardis
The New England Journal of Medicine|March 1, 2013
The implications of clonal genome evolution for cancer medicineSamuel Aparicio, Carlos Caldas
Cell|September 22, 2009
p53: a new kingpin in the stem cell arenaSamuel Aparicio, Connie J Eaves
Nature Reviews. Cancer|April 25, 2015
Examining the utility of patient-derived xenograft mouse modelsSamuel Aparicio, Manuel Hidalgo, Andrew L Kung
Cold Spring Harbor Perspectives in Medicine|May 1, 2024
Breast CancerJane E Visvader, Jeffrey M Rosen, Samuel Aparicio
Current Opinion in Genetics & Development|March 6, 2012
Opening Pandora's Box--the new biology of driver mutations and clonal evolution in cancer as revealed by next generation sequencingQianli C Ma, Catherine A Ennis, Samuel Aparicio
Clinical Chemistry|December 4, 2013
The omics of triple-negative breast cancersHong Xu, Peter Eirew, Sarah C Mullaly, et al.
The EMBO Journal|February 12, 2013
A new genome-driven integrated classification of breast cancer and its implicationsSarah-Jane Dawson, Oscar M Rueda, Samuel Aparicio, et al.
Virchows Archiv : an International Journal of Pathology|April 26, 2008
Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?Gulisa Turashvili, Malcolm Hayes, Blake Gilks, et al.
Scientific Reports|May 8, 2021
Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461Tehmina Masud, Charles Soong, Hong Xu, et al.
Pageof 14